研究文章
分析和研究流行病学特征和预后的肾病综合症在新疆和黑龙江
|
| 类型的NS |
|
新疆(
) |
黑龙江(
) |
价值一个 |
|
| 主要NS |
221例(80.36%) |
66例(78.57%) |
0.756 |
|
膜性肾病 |
81例(36.65%) |
38 (57.58%) |
|
| IgA肾病 |
46 (20.81%) |
15 (22.73%) |
|
| 价格上调 |
32 (14.48%) |
5 (7.58%) |
|
| 系膜增生性肾小球肾炎 |
30 (13.57%) |
3 (4.55%) |
|
| 局灶性节段性肾小球硬化 |
11 (4.98%) |
2 (3.03%) |
|
| Membranoproliferative肾小球肾炎 |
5 (2.26%) |
1 (1.52%) |
|
| Endocapillary增生性肾小球肾炎 |
13 (5.88%) |
1 (1.52%) |
|
| 新月形的肾小球肾炎 |
3 (1.36%) |
1 (1.52%) |
|
| 二次NS |
54 (19.64%) |
18 (21.43%) |
|
|
肝炎B-associated肾炎 |
1 (1.85%) |
2 (11.11%) |
|
| 糖尿病肾病 |
9 (16.67%) |
2 (11.11%) |
|
| 红斑狼疮肾病 |
20 (37.04%) |
5 (27.78%) |
|
| 紫癜性肾炎 |
5 (9.26%) |
2 (11.11%) |
|
| 淀粉样变肾病 |
5 (9.26%) |
1 (5.56%) |
|
| 历史进程膜性肾病 |
4 (7.41%) |
3 (16.67%) |
|
| 降肾损伤 |
5 (9.26%) |
2 (11.11%) |
|
| 阻力指标肾病也许可以ANCA-related |
3 (5.56%) |
0 (0.00%) |
|
| 其他 |
2 (3.70%) |
1 (5.56%) |
|
|
|
|
一个主要NS和次要NS。
|
